tradmap

YDES YD Bio Ltd

$5.95 -0.83%

Data as of close

Healthcare · Services-Medical Laboratories

YD Bio Ltd (YDES) is a healthcare company in the Services-Medical Laboratories industry, with a market capitalization of $421 million. Shares last traded at $5.95, 61.8% below their 52-week high. Over the past year the stock is down 68.0%. Revenue grew 16.9% year over year.

Market Cap
$421M
Shares Out
70.8M
EPS (TTM)
-$0.12
P/E (TTM)*
—
P/S Ratio
705.74
P/B Ratio
—
Dividend / Share
—
Dividend Yield
—
52-Week High
$15.56
52-Week Low
$1.83
Volume (venue)
2,803
Avg Vol (3m, venue)
5,689.778

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+11.63%
1M
-26.54%
3M
+162.11%
6M
+12.90%
YTD
-50.79%
1Y
-68.01%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
52.20
SMA (50)
$5.18
SMA (200)
$5.97
Price vs SMA50
+14.88%
Price vs SMA200
-0.42%
ATR (14)
$0.72

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$596817
Net Income
-$8M
Gross Margin
28.1%
Operating Margin
-883.3%
Net Margin
—
Return on Equity
291.0%
Return on Assets
-60.3%
Current Ratio
5.88
Debt / Equity
-5.83
Revenue Growth (YoY)
+16.9%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2025-12-31. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Services-Medical Laboratories peers

YDES vs 14 industry peers (Services-Medical Laboratories), by market cap. Data as of close

P/S vs peers
705.74 / 5.00 med
+14008% premium
1–14 of 14
NTRANatera, Inc.$54.6B—20.18-7.1%-8.49%
LHLabcorp$28.9B28.771.986.9%-1.65%
DGXQuest Diagnostics$27.6B24.442.339.5%-0.44%
GHGuardant Health, Inc.$22.9B—19.38-38.3%-4.45%
CAICaris Life Sciences, Inc.$9.1B86.269.1610.6%-6.50%
GRALGrail, Inc.$6.0B———-6.79%
RDNTRadnet, Inc.$5.8B—2.54-0.9%-0.54%
BLLNBilliontoone, Inc.$5.2B138.0913.109.5%-2.52%
CDNACaredx, Inc.$4.5B35.089.0725.9%-1.68%
VCYTVeracyte, Inc.$3.9B34.457.0220.4%-1.87%
CELCCelcuity Inc.$3.3B———-2.90%
FTREFortrea Holdings Inc.$1.9B—0.72-2.6%-5.99%
PSNLPersonalis, Inc.$1.7B———-0.44%
LMRILumexa Imaging Holdings, Inc.$1.1B———-2.32%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.